Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
Cancers (Basel). 2023 Mar 3;15(5):1580. doi: 10.3390/cancers15051580.
Cancers (Basel). 2023.
PMID: 36900372
Free PMC article.
The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial.
Rody A, Karn T, Solbach C, Gaetje R, Munnes M, Kissler S, Ruckhäberle E, Minckwitz GV, Loibl S, Holtrich U, Kaufmann M.
Rody A, et al. Among authors: minckwitz gv.
Breast. 2007 Jun;16(3):235-40. doi: 10.1016/j.breast.2007.02.006. Epub 2007 Apr 20.
Breast. 2007.
PMID: 17449250
Item in Clipboard
Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC) ± bevacizumab - results of the randomised GeparQuinto study (GBG 44).
Huober J, Fasching PA, Hanusch C, Rezai M, Eidtmann H, Kittel K, Hilfrich J, Schwedler K, Blohmer JU, Tesch H, Gerber B, Höß C, Kümmel S, Mau C, Jackisch C, Khandan F, Costa SD, Krabisch P, Loibl S, Nekljudova V, Untch M, Minckwitz Gv.
Huober J, et al. Among authors: minckwitz gv.
Eur J Cancer. 2013 Jul;49(10):2284-93. doi: 10.1016/j.ejca.2013.02.027. Epub 2013 Mar 27.
Eur J Cancer. 2013.
PMID: 23541564
Clinical Trial.
Item in Clipboard
Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.
Rody A, et al.
Zentralbl Gynakol. 2006 Apr;128(2):76-81. doi: 10.1055/s-2006-921508.
Zentralbl Gynakol. 2006.
PMID: 16673249
Clinical Trial.
Item in Clipboard
State of the art in neoadjuvant therapy of breast cancer.
Minckwitz Gv, Fontanella C.
Minckwitz Gv, et al.
EJC Suppl. 2013 Sep;11(2):284-5. doi: 10.1016/j.ejcsup.2013.07.043.
EJC Suppl. 2013.
PMID: 26217146
Free PMC article.
Review.
No abstract available.
Item in Clipboard
Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolation.
Jackisch C, Scappaticci FA, Heinzmann D, Bisordi F, Schreitmüller T, Minckwitz Gv, Cortés J.
Jackisch C, et al. Among authors: minckwitz gv.
Future Oncol. 2015;11(1):61-71. doi: 10.2217/fon.14.187.
Future Oncol. 2015.
PMID: 25163910
Item in Clipboard
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study.
Bauknecht T, Hefti A, Morack G, Villena-Heinsen C, Wallwiener D, Elling D, Minckwitz GV, Mansouri K, Blatter J, Breitbach GP.
Bauknecht T, et al. Among authors: minckwitz gv.
Int J Gynecol Cancer. 2003 Mar-Apr;13(2):130-7. doi: 10.1046/j.1525-1438.2003.13039.x.
Int J Gynecol Cancer. 2003.
PMID: 12657112
Clinical Trial.
Item in Clipboard
Cite
Cite